Arkolith/Insider Trading/TXMD/Form 4

Walker Marlan D

Chief Executive OfficerTherapeuticsMD, Inc. (TXMD) · full profile →Form 4 · filed Dec 7, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$44K
Net Open-Market Flow
-$44K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 7, 2023Sell(S)5K$2.24$10K63K
Dec 6, 2023Sell(S)15K$2.31$33K67K
Dec 5, 2023Option exercise(M)70K—$082K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 5, 2023Option exercise(M)70K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-057725) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML